Annals of Family Medicine
NOVEMBER 20, 2024
’s (2006) framework. long-term nursing homes, clinics), highlighting their perceived needs. Objectives: To synthesize current knowledge about the perceived needs of family physicians regarding their mental health during infectious catastrophes.
FDA Law Blog
MARCH 7, 2024
Clissold — The trio of CDER, CBER, and CDRH released a new draft guidance titled “ Use of Data Monitoring Committees in Clinical Trials ” that revises the 2006 guidance “Establishment and Operation of Clinical Trial Data Monitoring Committees” and, when final, will replace the 2006 guidance.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Physician's Weekly
JUNE 15, 2025
They evaluated 442 participants from the Collaborative Retrospective Study of Retinal Optical Coherence Tomography in Neuromyelitis optica (CROCTINO) cohort for comorbidities which included 515 individuals—369 with AQP4-NMOSD, 54 with MOGAD, and 58 with DN-NMOSD—meeting the 2006 and 2015 diagnostic criteria for NMOSD.
Today's Hospitalist
APRIL 24, 2025
That checklist includes patient demographics and the individual patient’s clinical needs. ” Phyllis Maguire has been Executive Editor of Today’s Hospitalist since 2006. Both the bed assignment countermeasure and the nursing handoff come with time expectations. Based in Bucks County, Pa.,
FDA Law Blog
FEBRUARY 4, 2024
Mullen — On January 18, 2024, the director of FDA’s Center for Devices and Radiological Health and the chief medical officer and acting director of CMS’ Center for Clinical Standards and Quality issued a joint press release supporting FDA’s recent proposed rule regulating Laboratory Developed Tests (LDTs). Javitt & Allyson B.
PEMBlog
OCTOBER 26, 2023
“Clinically, Meckel diverticulum should be suspected in any child younger than 2 years of age with painless rectal bleeding. STAT Pearls, 2023 Wrap Up Meckel diverticulum is a congenital anomaly of the small intestine that can present with various clinical manifestations, including rectal bleeding and obstruction. ” An et.
FDA Law Blog
NOVEMBER 1, 2023
Regulating LDTs: A Long and Winding Road In what might sound to some like protesting too much, the PR invokes FDA’s longstanding assertion that IVDs “manufactured” by laboratories are medical devices and that clinical laboratories that develop tests are acting as manufacturers. FDA’s position is, however, only one side of the story.
Expert insights. Personalized for you.
130 
Let's personalize your content